Report Description -

Summary
 
 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney Disease Pipeline Review, H1 2017, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders pipeline landscape.
 
 Hyperphosphatemia, that is, abnormally high serum phosphate levels, can result from increased phosphate intake, decreased phosphate excretion, or a disorder that shifts intracellular phosphate to extracellular space. This condition is most commonly seen in patients with chronic kidney disease. Signs and symptoms include fatigue, nausea, sleep disturbances, shortness of breath, bone and joint pain, pruritus and rash. Treatment includes phosphate binders and diuretics.
 
 Report Highlights
 
 Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Hyperphosphatemia In Chronic Kidney Disease Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type.
 
 The Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders pipeline guide also reviews of key players involved in therapeutic development for Hyperphosphatemia In Chronic Kidney Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 3, 2, 1, 1 and 5 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
 
 Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders.
• The pipeline guide reviews pipeline therapeutics for Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders by companies and universities/research institutes based on information derived from company and industryspecific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

Reasons to buy

1. Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
2. Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
3. Find and recognize significant and varied types of therapeutics under development for Hyperphosphatemia In Chronic Kidney Disease Nutritional Disorders.
4. Classify potential new clients or partners in the target demographic.

Download free sample of this report @

https://www.grandresearchstore.com/report-sample/hyperphosphatemia-in-chronic-kidney-disease---pipeline-review-h1-2017

Table Of Contents -

Global Markets Direct Report Coverage
 Hyperphosphatemia In Chronic Kidney Disease Overview
 Hyperphosphatemia In Chronic Kidney Disease Therapeutics Development
 Pipeline Overview
 Pipeline by Companies
 Pipeline by Universities/Institutes
 Products under Development by Companies
 Products under Development by Universities/Institutes
 Hyperphosphatemia In Chronic Kidney Disease Therapeutics Assessment
 Assessment by Target
 Assessment by Mechanism of Action
 Assessment by Route of Administration
 Assessment by Molecule Type
 Hyperphosphatemia In Chronic Kidney Disease Companies Involved in Therapeutics Development
 3SBio Inc
 Ardelyx Inc
 Daiichi Sankyo Company Ltd
 Medice Arzneimittel Putter GmbH & Co KG
 OPKO Health Inc
 PDX Pharmaceuticals LLC
 Shield Therapeutics Plc
 Spectrum Pharmaceuticals Inc
 Toray Industries Inc

For More Details VISIT @ -

https://www.grandresearchstore.com/life-sciences/hyperphosphatemia-in-chronic-kidney-disease---pipeline-review-h1-2017

Contact Us -

276 5th Avenue, New York , NY 10001, United States

Int’l: +1(212)-634–4884 / +1(646)-781–7170

Fax: +1(212)-634–4885

help@grandresearchstore.com